| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/04/2008 | US7338970 Containing microcrystalline cellulose, lubricant, colloidal silica and lactose; use in treating depression, Parkinson's disease and severe psychotic disorders, such as schizophrenia and schizoaffective disorders. |
| 03/04/2008 | US7338946 Indazolium trans-[tetrachlorobis(1H-indazol)-ruthenate(III)]; easily water-soluble; exhibits a high effectiveness in the treatment of cancer illnesses |
| 03/04/2008 | US7338939 Administering composition comprising hydrocodone covalently bound to a peptide; decreasing the bioavailability by intravenous or intranasal administration |
| 03/04/2008 | US7338931 Administering a hyaluronic acid and an insulin for treating diabetes; structure compacted due to the passing of the structure over its point of collapse with buried polar groups and a minimum size; the hyaluronic acid surrounds the insulin |
| 03/04/2008 | US7338928 System for releasing encapsulated active ingredients |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 03/04/2008 | US7338665 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 03/04/2008 | US7338663 Expandable osmotic composition and coating suspension |
| 03/01/2008 | CA2598060A1 Methods and compositions for the treatment and prevention of cancer |
| 02/28/2008 | WO2008024715A2 Tonsillitis treatment |
| 02/28/2008 | WO2008024700A2 Tonsillitis treatment |
| 02/28/2008 | WO2008024006A2 Pharmaceutical preparation in a gel form |
| 02/28/2008 | WO2008023999A1 A composition to improve delivery of an active agent |
| 02/28/2008 | WO2008023818A1 Fiber and method for production of fiber |
| 02/28/2008 | WO2008023807A1 Stabilized pharmaceutical composition |
| 02/28/2008 | WO2008023784A1 Agent for amelioration of ophthalmic circulatory disorder |
| 02/28/2008 | WO2008023384A1 Propofol emulsion compositions for intravenous administration |
| 02/28/2008 | WO2008023378A1 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 02/28/2008 | WO2007144189A3 Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers |
| 02/28/2008 | WO2007139818A3 Pharmacological treatment of cognitive impairment |
| 02/28/2008 | WO2007117581A3 Stabilized transdermal bupropion preparations |
| 02/28/2008 | WO2007052289B1 Novel dispersible tablet composition |
| 02/28/2008 | WO2006125153A3 Formulations for alteration of biophysical properties of mucosal lining |
| 02/28/2008 | US20080051740 Vaginal drug delivery system and method |
| 02/28/2008 | US20080051564 Delivery of pharmaceutical agents via the human insulin receptor |
| 02/28/2008 | US20080051561 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080051469 Compositions and Methods for Targeted in Vitro and in Vivo Drug Delivery to Mammalian Cells Via Bacterially Derived Intact Minicells |
| 02/28/2008 | US20080051468 Dual Phase Cosmetic Composition |
| 02/28/2008 | US20080051364 Therapeutic Treatment of Accelerated Bone Resorption |
| 02/28/2008 | US20080051329 FSH and FSH variant formulations, products and methods |
| 02/28/2008 | US20080050461 Nanoparticulate compositions of angiogenesis inhibitors |
| 02/28/2008 | US20080050447 Residual solvent extraction method and microparticles produced thereby |
| 02/28/2008 | US20080050439 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections |
| 02/28/2008 | US20080050438 Dry compositions |
| 02/28/2008 | US20080050435 Temperature Sensitive Polymers |
| 02/28/2008 | US20080050434 Novel Composition for Topical Delivery |
| 02/28/2008 | US20080050425 Combination Chemotherapy Comprising 5-Fluorouracil or a Derivative Thereof and a Liposomal Platinum Complex |
| 02/28/2008 | US20080050421 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050420 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050395 Methods for preparing and delivering adjuvant compositions |
| 02/28/2008 | US20080050388 Specified complementary determining region (CRD) amino acid sequences; specific binding activity for a cryptic collagen epitope; angiogenesis inhibition, antimetastasis, and tumor-targeted therapy uses |
| 02/28/2008 | US20080050383 Immunotherapy for clearing pathological tau conformers |
| 02/28/2008 | US20080050376 Compositions And Uses Thereof For Identifying And Targeting Provasopressin-Expressing Cancer Cells |
| 02/28/2008 | US20080050352 Pharmaceutical Composition Comprising Botulinum, a Non Ionic Surfactant, Sodium Chloride and Sucrose |
| 02/28/2008 | US20080050339 Stable liquid interferon formulations |
| 02/28/2008 | US20080050338 Stable liquid interferon formulations |
| 02/28/2008 | US20080050320 Skin care compositions containing a hydrophobic material and related methods |
| 02/28/2008 | US20080050311 Monoclonal Antibody hPAM4 |
| 02/28/2008 | DE19955576B4 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 02/28/2008 | DE102006039273A1 Pyrogenes Siliciumdioxid zur Verwendung als Hilfsstoff in pharmazeutischen und kosmetischen Zusammensetzungen Fumed silica for use as an excipient in pharmaceutical and cosmetic compositions |
| 02/28/2008 | CA2707204A1 Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 02/28/2008 | CA2662754A1 Sorbic acid analog co-crystals |
| 02/28/2008 | CA2661618A1 Stabilized pharmaceutical composition |
| 02/28/2008 | CA2661319A1 Conjugates of rgd peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses |
| 02/27/2008 | EP1891975A1 Anti-allergic complex molecules |
| 02/27/2008 | EP1891969A2 Novel anti-allergic agents |
| 02/27/2008 | EP1891956A1 Solubilization preparation |
| 02/27/2008 | EP1891943A2 Nanoparticles comprising chitosan and cyclodextrin |
| 02/27/2008 | EP1891143A1 Polymer-based serum albumin substitute |
| 02/27/2008 | EP1891102A2 Fusion protein of antibody l19 against fibronectin ed-b and interleukin 12 |
| 02/27/2008 | EP1890723A2 Stabilised il-21 compositions |
| 02/27/2008 | EP1890706A2 Process for the preparation and isolation of phosphatides |
| 02/27/2008 | EP1890698A1 A method of manufacturing a nicotine delivery product |
| 02/27/2008 | EP1890687A1 Stable pharmaceutical gel of diclofenac sodium |
| 02/27/2008 | EP1890546A1 A composition to enhance the bioavailability of curcumin |
| 02/27/2008 | EP1773399B1 Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses |
| 02/27/2008 | EP1605847A4 Antibody-targeted photodynamic therapy |
| 02/27/2008 | EP1496873B1 Chewable soft capsule |
| 02/27/2008 | EP1476193B1 A weight management system for obese animals |
| 02/27/2008 | EP1474113A4 Edible pga coating composition |
| 02/27/2008 | EP1458364B1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus |
| 02/27/2008 | EP1351685B1 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
| 02/27/2008 | EP1333812B1 Microgranules based on active principle and method for making same |
| 02/27/2008 | EP1237872B1 Compounds and compositions for delivering active agents |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | EP1137758B1 Method and composition for preserving adenoviruses |
| 02/27/2008 | EP1102792B1 Thermally-inhibited starch prepared with oligosaccharides |
| 02/27/2008 | EP1089740B1 Compositions for the treatment of cdad initiated by c. difficile toxin b |
| 02/27/2008 | CN101133322A Method for analyzing activated polyethylene glycol compounds |
| 02/27/2008 | CN101133102A Hyaluronic acid linked with a polymer of an alpha hydroxy acid |
| 02/27/2008 | CN101133084A Anti-il-1r1 single domain antibodies and therapeutic uses |
| 02/27/2008 | CN101133082A Acylated GLP-1 compounds |
| 02/27/2008 | CN101132813A BLYS fusion proteins for targeting BLYS receptor and methods for treatment of B-cell proliferative disorders |
| 02/27/2008 | CN101132812A Polymer-based compositions and conjuates of HIV entry inhibitors |
| 02/27/2008 | CN101132803A Tissue engineering edible meat and method of manufacturing the same |
| 02/27/2008 | CN101132801A Composition for preparing carbon dioxide preparation for external use |
| 02/27/2008 | CN101132775A Tigecycline compositons and methods of preparation |
| 02/27/2008 | CN101132774A Process for the production of calcium compositions in a continuous fluid bed |
| 02/27/2008 | CN101132770A Nanoparticulate candesartan formulations |
| 02/27/2008 | CN101130606A Water dispersible magnetic polymer microsphere, preparing method and application of the same |
| 02/27/2008 | CN101130575A Chitosan quaternary ammonium salt nano grain with hydrated sheath coating and method for preparing the same |
| 02/27/2008 | CN101130432A Fumed silica for use as auxiliary in pharmaceutical and cosmetic compositions |
| 02/27/2008 | CN101130107A Chitosan polyvinyl alcohol gel rubber containing nano granule of hydroxyapatite, producing method and uses of the same |
| 02/27/2008 | CN101130089A Nucleoside phosphorus acylated coupling chitosan derivant and method of producing the same and application of the same |
| 02/27/2008 | CN101130088A Supermolecule water soluble freeze drying matter of indissoluble medicament and method of preparing the same |
| 02/27/2008 | CN101130087A Medicament carrier solution for abdominal cavity chemotherapy and pharmaceutical composition thereof |
| 02/27/2008 | CN101130086A Method for preparing drug administration carrier of gene with polyethylene imine beautify chitosan |
| 02/27/2008 | CN101130085A Nano montmorillonite for restraining bacterium and method of preparing the same |
| 02/27/2008 | CN101130080A Gelling agent for controlling and releasing 5-HT* acceptor antagon and method of preparing the same |
| 02/27/2008 | CN101130071A Vaccine |